Cervical cancer screening
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?women aged between 25 and 65 years in line with cervical cancer screening guidelines. ?Those scheduled for Pap smear screening during the study period. ?Women willing to provide written informed consent ?Women with no douching or vaginal medications for the preceding 48 hours ?Women who had no sexual intercourse for the preceding 48 hours
Exclusion criteria
Exclusion criteria: ?Women that were virgins ?Pregnant women ? Recent sexual intercourse ?Those with obvious cervical pathology. ?Women with active pelvic infection, cervicitis, or vaginitis, which can confound pain reporting. ?Women on hormone replacement therapy ?Those with a history of cervical surgery (e.g., LEEP, cone biopsy) or pelvic radiation, which may alter anatomy or sensation. ?Women with known allergy or hypersensitivity to lidocaine or any component of the gel. ?Recent use (within 24 hours) of systemic analgesics, sedatives, or local anaesthetics that could influence pain scoring.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of women with satisfactory Pap smear cytology in each group. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mean pain scores experienced during speculum insertion in each group. 2. Proportion of women willing to return for repeat Pap smear cytology testing. | — |
Countries
Nigeria
Contacts
Professor in the University of Nigeria Nsukka Nigeria